Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

A-Current Down-Modulated by ς Receptor in Frog Pituitary Melanotrope Cells Through a G Protein-Dependent Pathway

Olivier Soriani, Frank Le Foll, François Roman, François P. Monnet, Hubert Vaudry and Lionel Cazin
Journal of Pharmacology and Experimental Therapeutics April 1999, 289 (1) 321-328;
Olivier Soriani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Le Foll
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François Roman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François P. Monnet
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hubert Vaudry
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lionel Cazin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Gramicidin perforated patch-clamp recordings were used to study the effects of two ς 1 receptor ligands, (+)-N-cyclopropylmethyl-N-methyl-1,4-diphenyl-1-ethyl-but-3-en-1-ylamine hydrochloride (JO 1784) and (+)-pentazocine, on the transient outward potassium current (IA) in cultured frog melanotrope cells. (+)-Pentazocine reversibly decreased the current amplitude in a dose-dependent manner. The effects of (+)-pentazocine were mimicked by JO 1784 and were markedly reduced by the ς 1 receptor antagonist,N,N-dipropyl-2-[4-methoxy-3–2(2-phenylethoxy)phenyl]-ethylamine monohydrochloride (NE 100). Inactivation rate of IA was best fitted with a double exponential function, yielding time constants of 23.7 and 112.5 ms. (+)-Pentazocine (20 μM) accelerated the current decay, decreasing the time constants to 10.7 and 59 ms, respectively. Current-voltage experiments revealed that (+)-pentazocine (20 μM) did neither modify the open-state I/V curves nor the voltage dependence of IA. However, (+)-pentazocine (20 μM) shifted the steady-state inactivation curve toward more negative potentials and increased the time constant of the time-dependent removal of inactivation. In whole-cell experiments, internal dialysis of guanosine-5′-O-(3-thiophosphate) (100 μM) irreversibly prolonged the response to (+)-pentazocine. In addition, cholera toxin pretreatment (1 μg · ml−1; 12 h) suppressed the inhibition of IAby (+)-pentazocine (20 μM). It is concluded that in frog melanotrope cells, a cholera toxin-sensitive, G protein-dependent inhibition ofIA through a ς 1 receptor activation, at least partially, underlies the excitatory effect of ς ligands.

Footnotes

  • Send reprint requests to: Pr. Lionel Cazin, European Institute for Peptide Research (IFRMP 23), Laboratory of Cellular and Molecular Neuroendocrinology, Institut National de la Santé et de la Recherche Médicale U413, Unité Associée au Centre National de la Recherche Scientificque, University of Rouen, 76821 Mont-Saint-Aignan, France. E-mail:lionel.cazin{at}univ-rouen.fr

  • ↵1 This work was supported by grants from Institut National de la Santé et de la Recherche Médicale (U 413), the Institut de Recherche Jouveinal/Parke-Davis, the European Union (Human Capital and Mobility Program; ERBCHRXCT920017), and the Conseil Régional de Haute-Normandie. O.S. was a recipient of a scholarship from the Fonds de la Recherche et de la Technologie (Conventions Industrielles de Formation par la Recherche program).

  • ↵2 Current address: Institut de Recherche Jouveinal/Parke-Davis, 3–9 rue de la Loge, 94260 Fresnes, France.

  • ↵3 Current address: Institut National de la Santé et de la Recherche Médicale U 488, 80, Avenue du Général Leclerc, 94276 Le Kremlin Bicêtre, France.

  • Abbreviations:
    α-MSH
    α-melanocyte-stimulating hormone
    CTX
    cholera toxin
    GTPγS
    guanosine-5′-O-(3-thiophosphate)
    IA
    transient outward potassium current
    JO 1784
    (+)-N-cyclopropylmethyl-N-methyl-1,4-diphenyl-1-ethyl-but-3-en-1-ylamine hydrochloride
    NE 100
    N,N-dipropyl-2[4-methoxy-3-(2-phenylethoxy)phenyl]-ethylamine monohydrochloride
    • Received September 8, 1998.
    • Accepted December 2, 1998.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 289 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 289, Issue 1
1 Apr 1999
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A-Current Down-Modulated by ς Receptor in Frog Pituitary Melanotrope Cells Through a G Protein-Dependent Pathway
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

A-Current Down-Modulated by ς Receptor in Frog Pituitary Melanotrope Cells Through a G Protein-Dependent Pathway

Olivier Soriani, Frank Le Foll, François Roman, François P. Monnet, Hubert Vaudry and Lionel Cazin
Journal of Pharmacology and Experimental Therapeutics April 1, 1999, 289 (1) 321-328;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

A-Current Down-Modulated by ς Receptor in Frog Pituitary Melanotrope Cells Through a G Protein-Dependent Pathway

Olivier Soriani, Frank Le Foll, François Roman, François P. Monnet, Hubert Vaudry and Lionel Cazin
Journal of Pharmacology and Experimental Therapeutics April 1, 1999, 289 (1) 321-328;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Toxicity, Biological Activity, and Pharmacokinetics of TXU (Anti-CD7)-Pokeweed Antiviral Protein in Chimpanzees and Adult Patients Infected with Human Immunodeficiency Virus
  • Evaluation of Effect of Charge and Lipid Coating on Ability of 60-nm Nanoparticles to Cross an In Vitro Model of the Blood-Brain Barrier
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics